The invention is directed to a compound represented by the following structural formula and pharmaceutically acceptable salts thereof:
Compounds represented by this structural formula are kinase inhibitors and are therefore disclosed herein for the treatment of cancer. Definitions for the variables in the structural formula are provided herein.
本发明涉及以下结构式及其药学上可接受的盐所代表的化合物:此结构式所代表的化合物是激酶
抑制剂,因此在此披露用于治疗癌症。本结构式中变量的定义在此提供。